16 1705-1716.zipperer a. konnerth m. c. laux c. berscheid a. janek d. weidenmaier c. burian m. schilling n. a. slavetinsky c. marschal m. willmann m. kalbacher h. schittek b. brotz- oesterhelt h. grond s. peschel a. and krismer b.

springer singapore.wang m. carver j. j. phelan v. v. sanchez l. m. garg n. peng y. nguyen d. d. watrous j. kapono c. a. luzzatto-knaan t. porto c. bouslimani a. melnik a. v. meehan m. j. liu w.-t. crusemann m. boudreau p. d. esquenazi e. sandoval-calderon m. kersten r. d. pace l. a. quinn r. a. duncan k. r. hsu c.-c. floros d. j. gavilan r. g. kleigrewe k. northen t. dutton r. j. parrot d. carlson e. e. aigle b. michelsen c. f. jelsbak l. sohlenkamp c. pevzner p. edlund a. mclean j. piel j. murphyb.

a distantly related spirotetronate spirohexenolide a  has previously been analyzed in a bacterial cytological profiling assay which revealed that it rapidly permeabilized cells resulting in the collapse of the proton motive force.observation of spirohexenolide a in tumor cells revealed the binding to and modulation of human macrophage migration inhibitor factor.to examine whether phocoena- micin impacted mammalian cell development we employed our image-based cytological profiling platform a. hela cells remained viable after 24 h of incubation with phocoenamicin with only the two highest concentrations 73 and 146 mm showing subtle changes in cell morphology b. at these concentrations phocoenamicin clustered with known ionophores and mitochondrial decouplers suggesting that the mechanism of action moa is related to modification of ionic gradients across the cell membrane c. to further probe the moa we screened a bacillus subtilis essential gene knockdown crispri library andfigure 5. cytological profiling reveals clustering of phocoenamicin with ionophores.

although both phocoenamicin and fidaxomicin have stable mics across varying cation and ph conditions lack of sensitivity of an rna polymerase knock- down strain in b. subtilis suggests that phocoenamicin possesses a different mechanism of action to fidaxomicin which has been shown to target rna polymerase.together these results suggest phocoenamicin functions by an alternative mechanism to any of the existing treatments for c. dif f icile used in clinical practice.

maansson m. keyzers r. a. sims a. c. johnson a. r. sidebottom a. m. sedio b. e. klitgaard a. larson c. b. boya p c. a. torres- mendoza d. gonzalez d. j. silva d. b. marques l. m. demarqued.

j. tomasi s. jenkins s. macherla v. hoffman t. agarwal v. williams p. g. dai j. neupane r. gurr j. rodriguez a. m. c. lamsa a. zhang c. dorrestein k. duggan b. m. almaliti j. allard p.-m. phapale p. nothias l.-f. alexandrov t. litaudon m. wolfender j.-l. kyle j. e. metz t. o. peryea t. nguyen d.-t. vanleer d. shinn p. jadhav a. muller r. waters k. m. shi w. liu x. zhang l. knight r. jensen p. r. palsson b. o. pogliano k. linington r. g. gutierrez m. lopes n. p. gerwick w. h. moore b. s. dorrestein p. c. and bandeira n. 2016 sharing and community curation of mass spectrometry data with global natural products social molecular networking.

limited information is available on mortality rates of marine mammals from c. dif f icile infections however clostridium species are relevant to cetaceans and have been isolated from intestinal and fecal samples from dolphins and whales.an emerging threat to humans this pathogen has limited treatment options with current therapy consisting of an aggressive dosage of vancomycin andor fecal transplants to try to re-establish microbiome health.screening of phocoenami- cin against c. dif f icile atcc 700057 according to csli guidelines revealed comparable activity mic 2.6 mm to vancomycin mic 2.9 mm.biological activity of phocoenamicin mimics iono-phores.

both phocoenamicin and fidaxomicin possess a 6-deoxy sugar with an acetyl linkage to a chlorinated phenol prompting us to evaluate phocoenamicin against c. dif f icile.

we determined that phocoenamicin has the ability to effectively depolarize the membrane when compared to the positive control carbonyl cyanide m- chlorophenyl hydrazone .to determine whether phocoenamicin permeabilizes the membrane in a similar manner to spirohexenolide a we monitored propidium iodidepi fluorescence directly after treatment with 0.5x mic phocoenamicin in a microfluidic perfusion system  .

80 598- 608.sanchez l. m. cheng a. t. warner c. j. a. townsley l. peach k. c. navarro g. shikuma n. j. bray w. m. riener r. m. yildiz f. h. et al.

31 391-398.lessa f. c. winston l. g. and mcdonald l. c. 2015burden of clostridium dif f icile infection in the united states.

c. and gross c. a.

from these one isolate was selected for detailed chemical investigation resulting in the discovery of phocoenamicin a novel spirotetronate antibiotic with potent activity against mrsa and c. dif f icile.results and discussionsample collection and isolate prioritization for novel bioactives discovery.

this feature is observed in both phocoenamicin and fidaxomicin  a promising narrow spectrum antibiotic for treating c. dif f icile infections.

prioritization of micromonospora auratinigra from the harbor porpoise microbiota revealed the presence of a new glycosylated polyketide antibiotic phocoenamicin with potent activity against a broad panel of gram-positive organisms including the intestinal pathogen c. dif f icile.

